First Name: Tom
Age: 73
Location: Livingston, NJ
Years with Migraines: 60
Occupation: Retired (from marketing)

How long have you had migraines?

I’ve had migraines since I was 13 and being male in the 60s and 70s, males didn’t get migraines; it was a woman’s thing they told me. It wasn’t until later in life. I went to my daughter’s doctor and told him my symptoms and he was the one that validated that I do indeed have migraines.

When do you usually get migraines?

I also have Ménière’s and that was triggered by caffeine. From taking all the migraine medicines I ended up at the hospital with internal bleeding so after that I stopped that and all caffeine. I was also on a no alcohol diet for 4 or 5 years. Stopping those things helped to identify the triggers, which were: caffeine, alcohol and too much salt. While reducing or eliminating these didn’t end the migraines, it helped reduced them.

What have you tried pre-CEFALY?

A few years after my hospital stay, I tried every new migraine medicine I could find but none of them really worked. At one point my father had a heart attack and I was taking more of the anti-heart attack medicines than he was for the migraine.

What does your migraine feel like?

In my case it’s an incredible pain in the back of my head, right where the head and the neck join together. It’s almost like being hit back there with a bat but it stays there and also my forehead on the same side. Mine are 99% right-sided. Fortunately since using CEFALY I don’t have to contend with a lot of these things anymore.

How did you hear about CEFALY?

My daughter got a CEFALY a couple years ago. It helped her so I asked my ENT and he gave me a prescription.

What’s your CEFALY experience like?

I use it daily in the morning for prevention. I also use it when I get a migraine on an as needed basis. The CEFALY has worked wonders. The number of my migraines dropped 75-80% and those that I do get are less severe. They can now be treated with a little acetaminophen. I like the CEFALY so much that I bought a spare.

Wondering if CEFALY is right for you… 

Learn more about CEFALY migraine treatment and prevention and, of course, check with your doctor.

Want to share your story too? We’d love to hear from you! Please send an email to m DOT coder AT cefaly DOT us. Please include your name, contact information, and let us know where you’re located so we can set up a good time to talk.

Tagged with: , , , , , ,

The novel coronavirus, or COVID-19, and its health implications have understandably caused great concern across the globe, and with good reason. The World Health Organization has declared the virus a pandemic and said the number of affected countries has tripled in two weeks. There are now upward of 170,000 cases worldwide and more than 6,600 deaths.

People throughout the world are making adjustments to their daily lives. In some instances, patients are foregoing medical visits, pharmacy runs, and more. CEFALY is grateful to be able to continue to bring relief to migraine sufferers from the comfort of their own homes.

If you already have a CEFALY prescription, you can order electrodes to be shipped directly from our warehouse to your door. Each electrode may be reused for up to 20 applications, which means a $25 kit of three electrodes will last you approximately two months if you use your device once a day.

Need a prescription for at-home migraine relief with CEFALY? If your doctor offers telehealth services and is able to offer consultations via Skype, FaceTime, or another digital or telephone platform and you’d like to order a CEFALY device, ask them to send the prescription by email to: info@cefaly.us or fax a prescription to: (203) 309-6045. Speaking with your doctor remotely removes the risk of contracting the coronavirus in the waiting room, during a treatment, or potentially during your roundtrip commute.

If you already have a CEFALY device but it’s an older version – specifically, the CEFALY 1 that looks like a headband – consider upgrading by trading it in for the CEFALY DUAL. You’ll receive a $150 credit toward a new device that comes with two treatment programs, instead of one, and a battery that’s rechargeable by USB. This also means no more scrounging for batteries when you most need relief. For more information for our buy-back program in the U.S., click here. Your new device comes with a renewed 60-day money back guarantee.

The CEFALY DUAL offers a 60-minute ACUTE treatment intended to be used at the onset of a migraine to stop or alleviate the pain. It also features a 20-minute daily PREVENT treatment to help prevent future migraine attacks. In studies, people who used the CEFALY device every day saw a reduction in migraine days and reduced use of migraine medication. You may be able to cut back on your medication, reduce potential drug-related side effects, lower your pharmaceutical costs, and stockpile the medication you already have for an emergency (or avoid visiting a pharmacy to pick up a refill).

Migraine affects more than 38 million people in the U.S. and 1 billion worldwide. CEFALY can help you stay home, stay safe, and stay on top of your treatments.

Tagged with: , , , , , , , , , , , , , ,

For some, the terms “migraine” and “headache” are used interchangeably to describe tension-type or cluster headaches that are usually characterized by dull, mild or moderate pain. While uncomfortable, these headaches don’t usually stop you from doing your normal daily activities. In contrast, migraine headaches are more severe, often debilitating, and may include other symptoms described below.

Migraine Headaches (With and Without Aura)

The key features of migraine headaches are the duration, characteristics of pain, and associated symptoms. Migraines last from four to 72 hours and are typically located on one side of the head. The pain increases and decreases in a pulse-like manner. Associated with the pain are nausea/vomiting, increased sensitivity to light, and/or an increased sensitivity to sounds.

Some migraineurs also develop aura symptoms. For migraine with aura, these symptoms are fully reversible and last from 5-60 minutes prior to headache onset (see table below for details).

Non-Migraine Headaches

Each specific type of non-migraine headache has unique characteristics. The most common non-migraine headache is the tension-type headache (TTH). TTH has pain on both sides of the head and a constant pain often described as someone ‘squeezing’ the head. The headaches are not worsened with walking, movement, exercise, etc., and rarely have nausea symptoms. Additionally, unlike migraine headaches, non-migraine headaches may have either sensitivity to light or sensitivity to sound, but not both.

table that compares symptoms of migraine to headache

Learn more about how CEFALY treats migraine pain and ask your doctor if CEFALY migraine treatment and prevention is right for you.

Migraines may indicate that you have a serious medical condition. Have any persistent pain checked by a qualified healthcare professional.

The CEFALY DUAL device was featured on Good Morning America as a cutting-edge treatment for migraine. The segment focused on FDA-cleared technology for the treatment of acute migraine attacks. While CEFALY DUAL has an acute migraine treatment that can help stop a migraine in its tracks, it also has a setting for migraine prevention, which can be used daily to prevent a future migraine episode.

Katie, a longtime CEFALY user, shared her first-hand experience with the device. Among her favorite aspects – how effective and easy it is to use CEFAL. At one point, she tells ABC Medical Correspondent, Dr. Jennifer Ashton, that she gets to “set it and forget it.”

See the CEFALY portion of the segment in the video below.

And click here to view the full segment.

Tagged with: , , , , , , , , , , , , ,

CEFALY Technology is the manufacturer and now also the exclusive distributor of the CEFALY device and its accessories across the country

Click here to view the full press release on PRNewswire.

NEW YORK, January 14, 2020 _ CEFALY Technology is pleased to announce that their latest technology for the drug-free treatment of migraines, the CEFALY DUAL device, and its accessories are now available across Canada direct to consumer. Until recently, only the original CEFALY device was available to migraineurs in Canada and it was sold via distributor.

“We are excited to start the New Year on a new path,” said Jennifer Trainor-McDermott, CEO with CEFALY Technology. “We are developing very focused initiatives to help migraineurs across Canada access relief and more quickly. This strategic move to relocate distribution in-house will provide more flexibility to meet our growing demand.”

CEFALY has rapidly become a global brand, widely recognized among the migraine community, which is estimated to be around 1 billion worldwide1. The CEFALY device is the first FDA-cleared medical technology of its kind for the treatment of migraine headaches. It is a non-invasive device placed on the forehead that uses two distinct programs (ACUTE and PREVENT) to stimulate and desensitize the area research identifies as a center for migraine pain, the Trigeminal nerve. Since CEFALY is not a drug, it can be used as a standalone option or with an existing treatment. Patients who use the device consistently show a decrease in migraine days and in intake of migraine medication.

In addition to gaining access to CEFALY’s latest technology, consumers in Canada will experience the company’s newly refreshed brand and web presence: https://www.cefaly.com/en-ca

About CEFALY Technology

CEFALY Technology is a Belgium-based company, with US offices based in Wilton, Connecticut, specializing in electronics for medical applications. It has developed external cranial stimulation technology for applications in the field of neurology; in particular for treating migraines.

For more information about CEFALY Technology visit: https://www.cefaly.us.

For more information on purchasing CEFALY in Canada visit: https://www.cefaly.com/en-ca.

Sources

1 Migraine facts. American Migraine Foundation website. Accessed January 13, 2020

Tagged with: , , , , , , , , , , , ,